These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35992594)

  • 21. Thioredoxin, a novel oxidative stress marker and cognitive performance in chronic and medicated schizophrenia versus healthy controls.
    Zhang XY; Chen DC; Xiu MH; Yang FD; Tan YL; He S; Kosten TA; Kosten TR
    Schizophr Res; 2013 Feb; 143(2-3):301-6. PubMed ID: 23238053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The
    Wang P; Cai J; Ni J; Zhang J; Tang W; Zhang C
    Neuropsychiatr Dis Treat; 2016; 12():2875-2883. PubMed ID: 27853371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of the RBANS to Evaluate Cognition in Patients with Schizophrenia and Metabolic Syndrome: a Meta-Analysis of Case-Control Studies.
    Zheng W; Jiang WL; Zhang X; Cai DB; Sun JW; Yin F; Ren PC; Zhao M; Wu HW; Xiang YQ; Liang WN; Zheng W
    Psychiatr Q; 2022 Mar; 93(1):137-149. PubMed ID: 33751356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between decreased HDL levels and cognitive deficits in patients with bipolar disorder: a pilot study.
    Hui L; Yin XL; Chen J; Yin XY; Zhu HL; Li J; Yin GZ; Xu XW; Yang XN; Qian ZK; Jiang CX; Tang Z; Yang HB; Cheung EFC; Chan RCK; Jia QF
    Int J Bipolar Disord; 2019 Nov; 7(1):25. PubMed ID: 31761966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma total antioxidant status and cognitive impairments in schizophrenia.
    Zhang XY; Chen DC; Xiu MH; Tang W; Zhang F; Liu L; Chen Y; Liu J; Yao JK; Kosten TA; Kosten TR
    Schizophr Res; 2012 Aug; 139(1-3):66-72. PubMed ID: 22555016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preliminary evidence of an interaction between the FOXP2 gene and childhood emotional abuse predicting likelihood of auditory verbal hallucinations in schizophrenia.
    McCarthy-Jones S; Green MJ; Scott RJ; Tooney PA; Cairns MJ; Wu JQ; Oldmeadow C; Carr V;
    J Psychiatr Res; 2014 Mar; 50():66-72. PubMed ID: 24360035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The interactive effect of genetic polymorphisms of IL-10 and COMT on cognitive function in schizophrenia.
    Wang J; Xu H; Wang D; Wei G; Zhou H; Wang L; Zhou Y; Zhang X
    J Psychiatr Res; 2021 Apr; 136():501-507. PubMed ID: 33127070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Face and object visual working memory deficits in first-episode schizophrenia correlate with multiple neurocognitive performances.
    Liu Y; Bi T; Zhang B; Kuang Q; Li H; Zong K; Zhao J; Ning Y; She S; Zheng Y
    Gen Psychiatr; 2021; 34(1):e100338. PubMed ID: 33728399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated activity of superoxide dismutase in male late-life schizophrenia and its correlation with clinical symptoms and cognitive deficits.
    Huo L; Lu X; Wu F; Chang C; Ning Y; Zhang XY
    BMC Psychiatry; 2021 Dec; 21(1):606. PubMed ID: 34863137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased Peripheral BDNF Levels and Cognitive Impairment in Late-Life Schizophrenia.
    Huo L; Zheng Z; Lu X; Wu F; Ning Y; Zhang XY
    Front Psychiatry; 2021; 12():641278. PubMed ID: 34239458
    [No Abstract]   [Full Text] [Related]  

  • 31. Meta-analysis of FOXP2 rs10447760 polymorphism with schizophrenia.
    Chen Y; Fang X; Wang Y; Zhang C
    Asian J Psychiatr; 2018 Jun; 35():50-51. PubMed ID: 29783134
    [No Abstract]   [Full Text] [Related]  

  • 32. Cognitive and serum BDNF correlates of BDNF Val66Met gene polymorphism in patients with schizophrenia and normal controls.
    Zhang XY; Chen DC; Xiu MH; Haile CN; Luo X; Xu K; Zhang HP; Zuo L; Zhang Z; Zhang X; Kosten TA; Kosten TR
    Hum Genet; 2012 Jul; 131(7):1187-95. PubMed ID: 22362486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FOXP2 polymorphisms in patients with schizophrenia.
    Sanjuan J; Tolosa A; González JC; Aguilar EJ; Moltó MD; Nájera C; de Frutos R
    Schizophr Res; 2005 Mar; 73(2-3):253-6. PubMed ID: 15653268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening of Cognitive Impairment in Schizophrenia: Reliability, Sensitivity, and Specificity of the Repeatable Battery for the Assessment of Neuropsychological Status in a Spanish Sample.
    De la Torre GG; Perez MJ; Ramallo MA; Randolph C; González-Villegas MB
    Assessment; 2016 Apr; 23(2):221-31. PubMed ID: 25934161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia I: sensitivity, reliability, and validity.
    Gold JM; Queern C; Iannone VN; Buchanan RW
    Am J Psychiatry; 1999 Dec; 156(12):1944-50. PubMed ID: 10588409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum C-Reactive Protein in Patients with Deficit Schizophrenia and the Relationship with Cognitive Function.
    Pan LH; Qian M; Qu W; Tang Q; Yan Y
    Neuropsychiatr Dis Treat; 2020; 16():2891-2897. PubMed ID: 33293814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between DBH 19 bp insertion/deletion polymorphism and cognition in first-episode schizophrenic patients.
    Hui L; Zhang X; Yu YQ; Han M; Huang XF; Chen DC; Wang ZR; Du WL; Kou CG; Yu Q; Kosten TR; Zhang XY
    Schizophr Res; 2013 Jul; 147(2-3):236-40. PubMed ID: 23707643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction between MAOA and FOXP2 in association with autism and verbal communication in a Korean population.
    Park Y; Won S; Nam M; Chung JH; Kwack K
    J Child Neurol; 2014 Dec; 29(12):NP207-11. PubMed ID: 24356376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. No association between common genetic variation in FOXP2 and language impairment in schizophrenia.
    McCarthy NS; Clark ML; Jablensky A; Badcock JC
    Psychiatry Res; 2019 Jan; 271():590-597. PubMed ID: 30554107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The speech and language FOXP2 gene modulates the phenotype of frontotemporal lobar degeneration.
    Padovani A; Cosseddu M; Premi E; Archetti S; Papetti A; Agosti C; Bigni B; Cerini C; Paghera B; Bellelli G; Borroni B
    J Alzheimers Dis; 2010; 22(3):923-31. PubMed ID: 20858950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.